Pharmaceutical

Subscribe

MarketWatch reports, Biogen Idec Inc. has received conditional approval of multiple sclerosis pill Fampyra in Europe, after a positive recommendation in May that followed an earlier rejection. The drug, developed

Pfizer Inc., the world’s largest drugmaker, accused Apotex Inc. in a lawsuit of infringing two U.S. patents for the nerve-pain drug Lyrica, reports Bloomberg. Apotex, based in Toronto, plans

British drugmaker GlaxoSmithKline PLC has reached a $40.75 million settlement with 37 states for selling potentially faulty and contaminated medicines produced at its former Puerto Rico factory during the last

PRNewswire reports, the U.S. Food and Drug Administration announced that a consent decree of condemnation, forfeiture and permanent injunction has been filed against H&P Industries Inc., The Triad Group

International Business Times reports, a group of major western pharmaceutical companies announced that they will significantly reduce the prices they charge for vaccines in the developing world. Merck & Co.,

The Associated Press reports, Johnson & Johnson said that its Cilag GmbH unit will expand its business in Russia by buying the over-the-counter brands of J B Chemicals & Pharmaceuticals

The Associated Press reports, Pfizer Inc. said that the Food and Drug Administration accepted its application for the experimental lung cancer treatment crizotinib, one of its key drug candidates. Pfizer

Chief Executive Officer Ian Read said he is reviewing the possible sale of four divisions with $18.3 billion in annual revenue, according to Bloomberg. Read, who took control of Pfizer

Reuters reports, the Linde Group will build and operate a large hydrogen and synthesis gas plant in the Chongqing Chemical Park in Western China in a joint enterprise with Chongqing

A. Schulman, Inc. announced that it will add one manufacturing line in its Sao Paulo, Brazil plant to accommodate increased demand for the company''s masterbatch and engineered plastics products, reports